IPW
FLNA

Impact Partnership Wealth’s Filana Therapeutics FLNA Stock Holding History

Impact Partnership Wealth’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,526
Closed -$25.4K – 1050
2023
Q3 		$25.4K Buy
+1,526
New +$30.2K 0.01% 465

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Impact Partnership Wealth's FLNA Position: Q4 2023 in Review

Impact Partnership Wealth sold out of Filana Therapeutics (FLNA) in Q4 2023, closing a stake of 1,526 shares — an estimated $25.4K sold.

Impact Partnership Wealth first reported a position in FLNA in Q3 2023 and held it in 1 quarter. The position peaked at $25.4K in Q3 2023. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2023.

  • Impact Partnership Wealth reported no remaining Filana Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Impact Partnership Wealth sold 1,526 Filana Therapeutics shares in Q4 2023, an estimated $25.4K.
  • Impact Partnership Wealth first reported a position in Filana Therapeutics in Q3 2023 and held it in 1 quarter.
  • Impact Partnership Wealth's Filana Therapeutics position peaked at $25.4K in Q3 2023.
  • 153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2023.

Based on Impact Partnership Wealth's 13F filing for Q4 2023, filed 14 Feb 2024.